Jan Vaclavik and Jiri Sliva
ACE inhibitors and sartans are two broadly used groups of drugs in the treatment of essential arterial hypertension. Even though they possess similar efficacy, there has been a continuous discussion concerning their preferences. Hence, the authors consider the pros and cons regarding the efficacy of these two groups in the context of relevant published data.
Teile diesen Artikel
English 
Spanish 
Chinese 
Russian 
French 
Japanese 
Portuguese 
Hindi 